General Information of Drug (ID: DM8DQV9)

Drug Name
Pelubiprofen
Synonyms Pelubi; Rubione; CS-670; DW-330; RS-2131
Indication
Disease Entry ICD 11 Status REF
Back pain ME84.Z Approved [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 258.31
Logarithm of the Partition Coefficient (xlogp) 3
Rotatable Bond Count (rotbonds) 3
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C16H18O3
IUPAC Name
2-[4-[(E)-(2-oxocyclohexylidene)methyl]phenyl]propanoic acid
Canonical SMILES
CC(C1=CC=C(C=C1)/C=C/2\\CCCCC2=O)C(=O)O
InChI
InChI=1S/C16H18O3/c1-11(16(18)19)13-8-6-12(7-9-13)10-14-4-2-3-5-15(14)17/h6-11H,2-5H2,1H3,(H,18,19)/b14-10+
InChIKey
AUZUGWXLBGZUPP-GXDHUFHOSA-N
Cross-matching ID
PubChem CID
5282203
CAS Number
69956-77-0
DrugBank ID
DB12150
TTD ID
D0X4JN

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Prostaglandin G/H synthase (COX) TTK0943 PGH1_HUMAN ; PGH2_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Anti-inflammatory effect of pelubiprofen, 2-[4-(oxocyclohexylidenemethyl)-phenyl]propionic acid, mediated by dual suppression of COX activity and LPS-induced inflammatory gene expression via NF- B inactivation. J Cell Biochem. 2011 Dec;112(12):3594-603.